Nasdaq Biotech Index on Pace for Biggest Gain in 6 Weeks

The video discusses the global business of pharmaceuticals and biotechnology, focusing on the NASDAQ's strong performance due to its biotech exposure. The biotech index saw a significant recovery, led by companies like Gilead Sciences, which received FDA approval for a hepatitis C treatment, and Relypsa, which reported positive study results. Endo International also experienced a stock surge despite a challenging year. The video highlights the impact of these developments on the stock market and the potential for short squeezes.

What recent performance trend was observed in the NASDAQ related to biotech stocks?

What was the percentage increase of the biotech index mentioned in the text?

Which company had its best day since February 3rd due to FDA approval?

What significant event contributed to the rise of Reliant Pharmaceuticals?

How much has Endo International's stock decreased over the year?